THE CALL FOR ABSTRACTS IS NOW OPEN – deadline extended until January 6!
20th Canadian Collaborative Mental Health Care Conference
May 10-11(Fri-Sat) | Sheraton Vancouver Airport Hotel | Richmond BC
Target audience: Interprofessional/intersectoral teams, family physicians and other primary care providers, mental health care providers, psychiatrists and psychologists, administrators and policy makers, other health disciplines working with primary care and/or community care, consumers and family members, educators and their students, and researchers.
Submit an abstract here https://www.xcdsystem.com/CCMHCC/abstract/index.cfm?ID=Ev8RhDk
Please note that you can make edits to the abstracts up until Jan 6, 2019! Notifications will be ready in February 2019.
The 2019 abstracts guidelines are available on our conference webpage https://ubccpd.ca/course/CCMHC2019.
Keynote Presentations include:
- Dr. Patricia Conrod, PhD. Professor, The Université of Montréal, Department of Psychiatry. The personality-targeted approach to treating substance use problems was first developed and tested by Dr. Patricia Conrod at McGill University in Montreal, Canada (1995-2000).
- Dr. Anna Ratzliff, MD, PhD. Associate Professor, The Department of Psychiatry & Behavioral Sciences, University of Washington. A national expert on collaborative care and specifically, on training teams to implement and deliver mental health treatment in primary care settings.
- Dr. Cornelia (Nel) Wieman, MD, FRCPC. President, Indigenous Physicians Association of Canada. The first female Indigenous psychiatrist (Anishnawbe – Little Grand Rapids First Nation, Manitoba). In January 2018, Nel joined the First Nations Health Authority in BC as a Senior Medical Officer, Mental Health & Wellness, in the FNHA’s Office of the Chief Medical Officer.
- Dr. Evan Wood, MD, PhD, ABIM, FASAM, FRCPC, ABAM Diplomat. Director, British Columbia Centre on Substance Use; Professor, The University of British Columbia. Dr. Wood is a general internal medicine specialist and diplomate of the American Board of Addiction Medicine who has been responsible for the creation of a number of addiction clinical and clinical training programs.